Famotidine Powder, For Suspension
Product Images NDC 80005-119

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 80005-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Chemstructure)

Chemical structure diagram of famotidine, showing the arrangement of its molecular components including sulfur, nitrogen, and oxygen atoms within the molecule.*

FDA Label Image

Containerlabel (Containerlabel)

Label for Famotidine for Oral Suspension USP 40 mg/5 mL powder for suspension, containing 400 mg of famotidine per bottle. The label includes directions for reconstitution, inactive ingredients, storage instructions, and manufacturer details for Carnegie Pharmaceuticals LLC. It states the suspension is for oral use only and to shake well before use, with a 50 mL volume when reconstituted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.